Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Lizard King's Trading Swamp -- Ignore unavailable to you. Want to Upgrade?

To: James R.Gross who wrote (7255)	10/9/1999 3:07:00 PM
From: kendall harmon	Read Replies (1) \| Respond to of 7396

AVGN has a really nice chart in the biotech sector, came out in one of my scans this week. clearstation.com

To: James R.Gross who wrote (7255)	10/9/1999 3:14:00 PM
From: kendall harmon	Respond to of 7396

Gman, LCBM looks good, although average daily volume is only 74,000 shares or so. These lower volume stocks are tougher in the current environment which is actually showing weaker liquidity in a lot of names. I especially like the rise in on balance volume recently: iqc.com Might be good to add to positions near the 50 day EMA clearstation.com

To: James R.Gross who wrote (7255)	10/11/1999 7:53:00 AM
From: kendall harmon	Read Replies (1) \| Respond to of 7396

LCBM--gman, I came across this piece and did not know if you had seen it <<Shares of Lifecore Biomedical, Inc. (LCBM) are trading higher today on news that the FDA has scheduled a review of the company's application for its ferric hyaluronate product, INTERGEL(TM) Adhesion Prevention Solution. LCBM appeared in the 3:00 p.m. EDT ProSearch run of Undervalued High Growth Stocks. The stock broke through resistance at $12 1/2 on strong volume and has been trending higher since. Today's intraday high of 15 5/8 represents a new 52-week high for LCBM. Investors should monitor the volume and price range closely during the end of the trading day. A close near the bottom of the intraday range on strong could indicate that the stock could converge with its 10-day moving average over the next few days. A close above $15 with strong volume would suggest that the stock could gap higher at the beginning of trading on Monday. LCBM manufactures surgical devices that are designed to reduce the incidence of post-surgical adhesions and titanium-based dental implants for the replacement of lost or extracted teeth. Revenues for the fiscal year ended June 30, 1999 rose $27.3 million, an increase of 6.6 percent over fiscal 1988 revenues of $25.6 million. Earnings per share rose to $0.13, compared to $0.02 a year ago. The company reported long-term debt of $6.6 million (debt-to-equity of 0.18) and negative cash flows from operating activities of $5.8 million. The company has 12.4 million shares outstanding and a float of 8.3 million.>> wallstreetcity.com